• Learning Objective 1: To understand how peptide therapeutics may overcome a significant druggability gap against cancer.
  • Learning Objective 2: How to extend the therapeutic window of drugs used to induce cell death in patients.
  • Learning Objective 3: To better understand challenges to drugging intracellular protein: protein interactions.
Session date: 
03/24/2022 - 12:00pm to 1:00pm CDT
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
James LaBelle, MD, PhD